Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 45, 2015 - Issue 6
674
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Biotransformation and mass balance of the SGLT2 inhibitor empagliflozin in healthy volunteers

, , , , , , , & show all
Pages 520-529 | Received 21 Oct 2014, Accepted 12 Dec 2014, Published online: 30 Dec 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Baptist Gallwitz. (2017) A safety evaluation of empagliflozin plus linagliptin for treating type 2 diabetes. Expert Opinion on Drug Safety 16:12, pages 1399-1405.
Read now
Atsunori Miyata, Masatoshi Hasegawa, Kenji Hachiuma, Haruyuki Mori, Nobuko Horiuchi, Akiko Mizuno-Yasuhira, Yukihiro Chino, Shigeji Jingu, Soichi Sakai, Yoshishige Samukawa, Yasuhiro Nakai & Jun-ichi Yamaguchi. (2017) Metabolite profiling and enzyme reaction phenotyping of luseogliflozin, a sodium–glucose cotransporter 2 inhibitor, in humans. Xenobiotica 47:4, pages 332-345.
Read now

Articles from other publishers (15)

Anil Kumar Goud Thallapalli & Ram Mohan Manda. (2023) Development and validation of Empagliflozin and Linagliptin simultaneous estimation in rat plasma using freezing lipid precipitation and SCX-SPE assisted HPLC–MS/MS method and its application in pharmacokinetic studies. Analytical Sciences.
Crossref
Yu Zhang, Panpan Xie, Yamei Li, Zhixing Chen & Aixin Shi. (2023) Mechanistic evaluation of the inhibitory effect of four SGLT-2 inhibitors on SGLT 1 and SGLT 2 using physiologically based pharmacokinetic (PBPK) modeling approaches. Frontiers in Pharmacology 14.
Crossref
Simon G. Wong & Shuguang Ma. 2023. Overcoming Obstacles in Drug Discovery and Development. Overcoming Obstacles in Drug Discovery and Development 137 174 .
Sha Chen, Ruben Coronel, Markus W. Hollmann, Nina C. Weber & Coert J. Zuurbier. (2022) Direct cardiac effects of SGLT2 inhibitors. Cardiovascular Diabetology 21:1.
Crossref
JÉSSICA B. DE JESUS, RAISSA A. DA CONCEIÇÃO, THAYNÁ R. MACHADO, MARIA L.C. BARBOSA, THAISA F.S. DOMINGOS, LUCIO M. CABRAL, CARLOS R. RODRIGUES, BÁRBARA ABRAHIM-VIEIRA & ALESSANDRA M.T. DE SOUZA. (2022) Toxicological assessment of SGLT2 inhibitors metabolites using in silico approach. Anais da Academia Brasileira de Ciências 94:suppl 3.
Crossref
Gangireddy Navitha Reddy, Chenkual Laltanpuii & Rajesh Sonti. (2021) Review on in vivo profiling of drug metabolites with LC-MS/MS in the past decade . Bioanalysis 13:22, pages 1697-1722.
Crossref
Ju-Hyun Kim, Dong Kyun Kim, Won-Gu Choi, Hye-Young Ji, Ji-Soo Choi, Im-Sook Song, Sangkyu Lee & Hye Suk Lee. (2020) In Vitro Metabolism of DWP16001, a Novel Sodium-Glucose Cotransporter 2 Inhibitor, in Human and Animal Hepatocytes. Pharmaceutics 12:9, pages 865.
Crossref
Namyi Gu, Sang-In Park, Hyewon Chung, Xuanyou Jin, SeungHwan Lee & Tae-Eun Kim. (2020) Possibility of pharmacokinetic drug interaction between a DPP-4 inhibitor and a SGLT2 inhibitor. Translational and Clinical Pharmacology 28:1, pages 17.
Crossref
Tamara Y. Milder, Sophie L. Stocker, Dorit Samocha-Bonet, Richard O. Day & Jerry R. Greenfield. (2019) Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes—cardiovascular and renal benefits in patients with chronic kidney disease. European Journal of Clinical Pharmacology 75:11, pages 1481-1490.
Crossref
Bruna Carolina Lui Dias, Mariana Millan Fachi, Michel Leandro Campos, Flávia Lada Degaut Degaut, Rosângela Gonçalves Peccinini & Roberto Pontarolo. (2019) A new HPLC–MS/MS method for the simultaneous quantification of SGLT2 inhibitors and metformin in plasma and its application to a pharmacokinetic study in healthy volunteers. Biomedical Chromatography.
Crossref
Priyanka A. Shah, Pranav S. Shrivastav & Archana George. (2019) Mixed-mode solid phase extraction combined with LC-MS/MS for determination of empagliflozin and linagliptin in human plasma. Microchemical Journal 145, pages 523-531.
Crossref
James E. Frampton. (2018) Empagliflozin: A Review in Type 2 Diabetes. Drugs 78:10, pages 1037-1048.
Crossref
Paresh Dandona & Ajay Chaudhuri. (2017) Sodium-glucose co-transporter 2 inhibitors for type 2 diabetes mellitus: An overview for the primary care physician. International Journal of Clinical Practice 71:5, pages e12937.
Crossref
Javier Saurina & Sonia Sentellas. (2017) Strategies for metabolite profiling based on liquid chromatography. Journal of Chromatography B 1044-1045, pages 103-111.
Crossref
John E. Anderson, Eugene E. WrightJr.Jr. & Charles F. ShaeferJr.Jr.. (2016) Empagliflozin: Role in Treatment Options for Patients with Type 2 Diabetes Mellitus. Diabetes Therapy 8:1, pages 33-53.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.